Financials
- Market Capitalization 1.54 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-79.2
Fiyat/satışlar oranı
4.13
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2137 | ANAB AnaptysBio, Inc. - Common Stock | 55.28 USD | -3.07% | -5.13% | +3.52% | +57.05% | 1.61 B USD | ||
| 2158 | BCAX Bicara Therapeutics Inc. - Common Stock | 23.42 USD | +1.30% | -4.53% | -12.77% | +62.19% | 1.55 B USD | ||
| 2167 | INVA Innoviva, Inc. - Common Stock | 21.08 USD | +1.49% | -0.33% | +0.52% | +18.29% | 1.52 B USD | ||
| 2168 | LBRX LB Pharmaceuticals Inc - Common Stock | 47.10 USD | -0.34% | -3.31% | +15.61% | +147.89% | 1.52 B USD |